Literature DB >> 25706964

Retraction and republication--ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data.

.   

Abstract

Entities:  

Year:  2015        PMID： 25706964      PMCID： PMC6005358          DOI： 10.1016/S0140-6736(14)62216-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  STEMI care in China: a world opportunity.

Authors:  Ajay J Kirtane; Gregg W Stone
Journal:  Lancet       Date:  2014-06-23       Impact factor: 79.321

2.  ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data.

Authors:  Jing Li; Xi Li; Qing Wang; Shuang Hu; Yongfei Wang; Frederick A Masoudi; John A Spertus; Harlan M Krumholz; Lixin Jiang
Journal:  Lancet       Date:  2014-06-23       Impact factor: 79.321
  2 in total
  3 in total

1.  Prevalence of hypertension, diabetes, and dyslipidemia, and their additive effects on myocardial infarction and stroke: a cross-sectional study in Nanjing, China.

Authors:  Shan Lu; Ming-Yang Bao; Shu-Mei Miao; Xin Zhang; Qing-Qing Jia; Shen-Qi Jing; Tao Shan; Xiao-Hong Wu; Yun Liu
Journal:  Ann Transl Med       Date:  2019-09

2.  High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Authors:  Yu Du; Yingxin Zhao; Yong Zhu; Chenping Hu; Jianwei Zhang; Qingwei Ji; Wei Liu; Hongya Han; Lixia Yang; Dai Zhang; Shan Tong; Zhijian Wang; Yonghe Guo; Xiaoli Liu; Yujie Zhou
Journal:  J Atheroscler Thromb       Date:  2019-02-15       Impact factor: 4.928

3.  Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study.

Authors:  Ying Yao; Ping Wang; Xiao-Zeng Wang; Xin Zhao; Wei Zhao; Tie-Nan Zhou; Lei Zhang
Journal:  Chin Med J (Engl)       Date:  2019-10-05       Impact factor: 2.628
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.